Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Hepatitis C virus
BY
Mohamed Ahmed
Mogahed
Mohamed Ahmed
Ghed
Mohamed Mahmoud
Kandeel
Section
:3
Mahmoud
Refaey
Mohamed
Mohamed
Mohamed
Esawy
Mohamed
Ahmed Abada
Salem Zayed
Mohamed El-
Salah El-Hagr
Sup : Dr / Naiera
Introduction
Why ?
hepatic artery;
What is Hepatitis ?
Hepatitis
Types of hepatitis
Hepatitis A: The hepatitis A virus is transmitted when fecal matter containing
the virus is ingested, most commonly through food. Infections with hepatitis A
are self-limited and never result in chronic infection or serious liver damage. A 2shot series vaccine is available (recommended for international travel) and can
provide life-long immunity
Hepatitis B: The hepatitis B virus is transmitted through blood and sexual fluids.
Unprotected sexual contact, injection drug use, and mother-to-child are the most
common routes of infection. Chronic infection is possible, and a high risk for
unimmunized infants and young children exposed to the virus. A 3-shot series
vaccine is available (required in most states for children in school) and can
provide life-long immunity
Types of hepatitis
Hepatitis D: The hepatitis D virus (also known as delta
Hepatitis C virus
However,
It
The most affected region are Africa , Central and East Asia .
Causes
The
HCV can also be transmitted sexually and can be passed from an infected mother
to her baby; however these modes of transmission are much less common.
Hepatitis C is not spread through breast milk, food or water or by casual contact
such as hugging, kissing and sharing food or drinks with an infected person.
Causes
Prevention
Primary
prevention
There is no vaccine for hepatitis C, therefore prevention of HCV infection depends upon
reducing the risk of exposure to the virus in health-care settings, in higher risk populations,
for example, people who inject drugs, and through sexual contact.
The
hand hygiene: including surgical hand preparation, hand washing and use of gloves;
testing of donated blood for hepatitis B and C (as well as HIV and syphilis);
Prevention
Secondary
Concequences
During the initial infection people often have mild or no symptoms. Occasionally
a fever, dark urine, abdominal pain, andyellow tinged skinoccurs.
The virus persists in the liver in about 75% to 85% of those initially infected.
Early on chronic infection typically has no symptoms. Over many years however,
it often leads toliver diseaseand occasionallycirrhosis.
In some cases, those with cirrhosis will develop complications such as
liver failure,liver cancer, oresophagealandgastric varices .
Concequences
Concequences
Symptoms
The
Symptoms
Symptoms
Analysis
HCV
1- Screening for anti-HCV antibodies with a serological test identifies people who have
been infected with the virus.
2- If the test is positive for anti-HCV antibodies, a nucleic acid test for HCV RNA (PCR) is
needed to confirm chronic HCV infection because about 1545% of people infected with
HCV spontaneously clear the infection by a strong immune response without the need for
treatment. Although no longer infected, they will still test positive for anti-HCV antibodies.
After a person has been diagnosed with chronic hepatitis C infection, they should have an
assessment of the degree of liver damage (fibrosis and cirrhosis). This can be done by
liver biopsy or through a variety of non-invasive tests.
In addition, these people should have a laboratory test to identify the genotype of the
hepatitis C strain.
Analysis
vaccine
Avaccinecapable
Most
vaccine
Genotypes
Genotypes
Treatments
1991:200
1
1991:200
1
Cure ratio: about 9% in genotype 1&4 , and about 30% in genotype 2&3
Cure ratio: about 29% in genotype 1&4 and about 32% in genotype 2&3.
Cure ratio: about 41% in genotype 1&4 , and about 75% in genotype 2 ,
3 , 5 & 6.
Treatments
Telaprevir or Boceprevir ( Act on Protease ) with Interferon .
Ribavirin .
Nov.
Cure ratio: 80% in genotype 1 & 4
2013
Treatments
Oct.
2014
Nov.
2014
Dec.
2014
Treatments
Ombitasvir/Paritaprevir/Ritonavir (Known in Egypt >
Qurevo)
July Cure ratio: 100% success (not used for patients with
2015 cirrhosis or liver function failure rate higher than the
medium)
DaclatasvirDaklinza(Need Ribavrin in presence of
cirrhosis )
July
2015 Cure ratio: exceeded 97%.
2016
Zepatier
Treatments
Treatments
Mechanis
m
Old Drugs
New Drugs
Management
Hepatitis
Summary
Liver
functional
histology
Hepatitis
C
Virus
What
is
Hepatitis
Types
of
Hepatitis
Any questions ?
Thank
you !